U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H26N2O
Molecular Weight 370.4867
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SAVOXEPIN

SMILES

N#CC1=CC2=C(OC3=CC=CC=C3C4=C2CCN(CC5CCCC5)CC4)C=C1

InChI

InChIKey=MUAHMQUPOQGKOQ-UHFFFAOYSA-N
InChI=1S/C25H26N2O/c26-16-19-9-10-25-23(15-19)21-12-14-27(17-18-5-1-2-6-18)13-11-20(21)22-7-3-4-8-24(22)28-25/h3-4,7-10,15,18H,1-2,5-6,11-14,17H2

HIDE SMILES / InChI

Molecular Formula C25H26N2O
Molecular Weight 370.4867
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Savoxepine (also known as cipazoxapine), a tetracyclic compound, possesses a potent neuroleptic-like effects. This compound acts via dopamine D(2)-receptor blockade. Savoxepine was studied in phase II clinical trials in Europe for the treatment of patients with psychotic disorders; however, these studied were discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Direct microtitre plate radioimmunoassay of savoxepine in unextracted plasma.
1996-02
Savoxepine fails to selectively influence glucose metabolism in the rat limbic system.
1994-03
Savoxepine: striatal dopamine-D2 receptor occupancy in human volunteers measured using positron emission tomography (PET).
1993
Neuroleptic profile of cipazoxapine (Savoxepine), a new tetracyclic dopamine antagonist: clinical validation of the hippocampus versus striatum ratio model of dopamine receptors in animals. A preliminary report.
1987-05
Patents

Sample Use Guides

In an open pilot-study 18 patients suffering from acute schizophrenic psychoses or paranoid syndromes were treated with savoxepine in an individually adapted dose range from 0.50 to 10 mg per day
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:30:27 GMT 2025
Edited
by admin
on Mon Mar 31 19:30:27 GMT 2025
Record UNII
13343J27CI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SAVOXEPIN
INN  
INN  
Official Name English
savoxepin [INN]
Preferred Name English
3-(CYCLOPENTYLMETHYL)-2,3,4,5-TETRAHYDRO-1H-DIBENZ(2,3:6,7)OXEPINO(4,5-D)AZEPINE-7-CARBONITRILE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C66883
Created by admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
Code System Code Type Description
FDA UNII
13343J27CI
Created by admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
PRIMARY
NCI_THESAURUS
C152310
Created by admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
PRIMARY
PUBCHEM
54359
Created by admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
PRIMARY
EVMPD
SUB10461MIG
Created by admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
PRIMARY
SMS_ID
100000084101
Created by admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
PRIMARY
EPA CompTox
DTXSID20229594
Created by admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
PRIMARY
ChEMBL
CHEMBL2105557
Created by admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
PRIMARY
INN
5907
Created by admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
PRIMARY
CAS
79262-46-7
Created by admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY